USPTO Grants Meliora Health Cancellation
Summary
The USPTO's Trademark Trial and Appeal Board (TTAB) has granted a cancellation proceeding against the MELIORA HEALTH mark. This decision, effective March 18, 2026, removes the mark's registration.
What changed
The USPTO's Trademark Trial and Appeal Board (TTAB) has granted a cancellation proceeding (TTAB92089846) concerning the MELIORA HEALTH mark, owned by Healios Ltd., at the request of Meliora Integrative Medicine. The decision, effective March 18, 2026, results in the removal of the mark's registration.
This action signifies the successful challenge to the MELIORA HEALTH mark. Legal professionals involved in trademark prosecution and litigation should note this outcome as it impacts the registrability and continued use of the mark. No specific compliance actions are required for other entities, as this is an individual case resolution.
Source document (simplified)
Cancellation: MELIORA HEALTH
Cancellation TTAB92089846-20260318 Kind: CAN Mar 18, 2026
Abstract
BD DECISION: CAN GRANTED
Plaintiff: Meliora Integrative Medicine
Defendant: Healios Ltd.
Mark at issue: MELIORA HEALTH
Filing Date
2025-10-21
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Courts & Legal alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: TTAB Proceedings publishes new changes.